Current status: 873 hESC lines, 3377 hiPSC lines, and 102 clinical studies, and 441 certificates
Monthly statistic from Dec 1, 2022
Posted on December 1, 2022
| total lines | 4250 |
| hESC lines | 873 |
| hiPSC lines | 3377 |
| derivation countries | 44 |
| projects | 249 |
| providers | 767 |
| clinical studies | 102 |
| subclones | 1829 |
| certificates | 441 |
| cell line certificates | 312 |
| project certificates | 129 |